Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

QUICK HEAL TECHNOLOGIES 2023-24 Annual Report Analysis
Mon, 19 Aug

QUICK HEAL TECHNOLOGIES has announced its results for the year ended March 2024. Let us have a look at the detailed performance review of the company during FY23-24.

QUICK HEAL TECHNOLOGIES Income Statement Analysis

  • Operating income during the year rose 4.9% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 833.5% YoY during the fiscal. Operating profit margins witnessed a fall and down at 6.0% in FY24 as against 0.7% in FY23.
  • Depreciation charges decreased by 21.2% increased by 0.0% YoY, respectively.
  • Other income declined by 3.3% YoY.
  • Net profit for the year grew by 278.8% YoY.
  • Net profit margins during the year grew from 2.3% in FY23 to 8.3% in FY24.

QUICK HEAL TECHNOLOGIES Income Statement 2023-24

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Net Sales Rs m 2,781 2,918 4.9%
Other income Rs m 221 214 -3.3%
Total Revenues Rs m 3,002 3,131 4.3%
Gross profit Rs m 19 176 833.5%
Depreciation Rs m 160 126 -21.2%
Interest Rs m 0 1 0.0%
Profit before tax Rs m 80 262 226.8%
Tax Rs m 16 20 21.6%
Profit after tax Rs m 64 242 278.8%
Gross profit margin % 0.7 6.0
Effective tax rate % 20.2 7.5
Net profit margin % 2.3 8.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Dear Reader: If You Invest in Midcap Stocks, this is for You

QUICK HEAL TECHNOLOGIES Balance Sheet Analysis

  • The company's current liabilities during FY24 stood at Rs 733 million as compared to Rs 719 million in FY23, thereby witnessing an increase of 1.9%.
  • Current assets rose 12% and stood at Rs 4 billion, while fixed assets fell 14% and stood at Rs 1 billion in FY24.
  • Overall, the total assets and liabilities for FY24 stood at Rs 5 billion as against Rs 5 billion during FY23, thereby witnessing a growth of 3%.

QUICK HEAL TECHNOLOGIES Balance Sheet as on March 2024

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Networth Rs m 4,102 4,270 4.1
 
Current Liabilities Rs m 719 733 1.9
Long-term Debt Rs m 0 0 0.0
Total Liabilities Rs m 4,933 5,092 3.2
 
Current assets Rs m 3,235 3,638 12.5
Fixed Assets Rs m 1,698 1,454 -14.4
Total Assets Rs m 4,933 5,092 3.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



QUICK HEAL TECHNOLOGIES Cash Flow Statement Analysis

  • QUICK HEAL TECHNOLOGIES's cash flow from operating activities (CFO) during FY24 stood at Rs 182 million on a YoY basis.
  • Cash flow from investing activities (CFI) during FY24 stood at Rs 62 million on a YoY basis.
  • Cash flow from financial activities (CFF) during FY24 stood at Rs 16 million, an improvement of 101% on a YoY basis.
  • Overall, net cash flows for the company during FY24 stood at Rs 259 million from the Rs 38 million net cash flows seen during FY23.

QUICK HEAL TECHNOLOGIES Cash Flow Statement 2023-24

Particulars No. of months 12 12 % Change
Year Ending Mar-23 Mar-24
Cash Flow from Operating Activities Rs m 308 182 -41.0%
Cash Flow from Investing Activities Rs m 1,852 62 -96.7%
Cash Flow from Financing Activities Rs m -2,122 16 -
Net Cash Flow Rs m 38 259 591.5%
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for QUICK HEAL TECHNOLOGIES

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 4.5, an improvement from the EPS of Rs 1.2 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 597.4, stands at 78.3 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 7.5 times, while the price to sales ratio stands at 11.0 times.
  • The company's price to cash flow (P/CF) ratio stood at 52.8 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Sales per share (Unadj.) Rs 52.4 54.5
TTM Earnings per share Rs 1.2 4.5
Diluted earnings per share Rs 1.2 4.5
Price to Cash Flow x 32.0 52.8
TTM P/E ratio x 111.8 78.3
Price / Book Value ratio x 2.3 4.6
Market Cap Rs m 9,378 19,463
Dividends per share (Unadj.) Rs 2.5 3.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for QUICK HEAL TECHNOLOGIES

  • Solvency Ratios
  • Current Ratio: The company's current ratio improved and stood at 5.0x during FY24, from 4.5x during FY23. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 202.6x during FY24, from 0.0x during FY23. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company improved and stood at 5.7% during FY24, from 1.6% during FY24. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 6.2% during FY24, from 2.0% during FY23. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company improved and stood at 4.8% during FY24, from 1.3% during FY23. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Current ratio x 4.5 5.0
Debtors’ Days Days 16 16
Interest coverage x 0.0 202.6
Debt to equity ratio x 0.0 0.0
Return on assets % 1.3 4.8
Return on equity % 1.6 5.7
Return on capital employed % 2.0 6.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how QUICK HEAL TECHNOLOGIES has performed over the last 5 years, please visit here.

QUICK HEAL TECHNOLOGIES Share Price Performance

Over the last one year, QUICK HEAL TECHNOLOGIES share price has moved up from Rs 184.2 to Rs 597.4, registering a gain of Rs 413.2 or around 224.3%.

Meanwhile, the S&P BSE IT Index is trading at Rs 41,690.4 (up 0.3%). Over the last one year it has moved up from 30,908.0 to 41,690.4, a gain of 10,782 points (up 34.9%).

Overall, the S&P BSE SENSEX is up 23.0% over the year.

(To know more, check out historical annual results for QUICK HEAL TECHNOLOGIES and quarterly results for QUICK HEAL TECHNOLOGIES)

Annual Report FAQs

What is the current share price of QUICK HEAL TECHNOLOGIES?

QUICK HEAL TECHNOLOGIES currently trades at Rs 601.5 per share. You can check out the latest share price performance of QUICK HEAL TECHNOLOGIES here...

What was the revenue of QUICK HEAL TECHNOLOGIES in FY24? How does it compare to earlier years?

The revenues of QUICK HEAL TECHNOLOGIES stood at Rs 3,131 m in FY24, which was up 4.3% compared to Rs 3,002 m reported in FY23.

QUICK HEAL TECHNOLOGIES' revenue has fallen from Rs 3,177 m in FY20 to Rs 3,131 m in FY24.

Over the past 5 years, the revenue of QUICK HEAL TECHNOLOGIES has grown at a CAGR of -0.4%.

What was the net profit of QUICK HEAL TECHNOLOGIES in FY24? How does it compare to earlier years?

The net profit of QUICK HEAL TECHNOLOGIES stood at Rs 242 m in FY24, which was up 278.8% compared to Rs 64 m reported in FY23.

This compares to a net profit of Rs 832 m in FY22 and a net profit of Rs 1,070 m in FY21.

Over the past 5 years, QUICK HEAL TECHNOLOGIES net profit has grown at a CAGR of -24.5%.

What does the cash flow statement of QUICK HEAL TECHNOLOGIES reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of QUICK HEAL TECHNOLOGIES reveals:

  • Cash flow from operations decreased in FY24 and stood at Rs 182 m as compared to Rs 308 m in FY23.
  • Cash flow from investments decreased in FY24 and stood at Rs 62 m as compared to Rs 1,852 m in FY23.
  • Cash flow from financial activity increased in FY24 and stood at Rs 16 m as compared to Rs -2,122 m in FY23.

Here's the cash flow statement of QUICK HEAL TECHNOLOGIES for the past 5 years.

(Rs m)FY20FY21FY22FY23FY24
From Operations706986800308182
From Investments1,477-9231,2571,85262
From Financial Activity-2,2141-2,142-2,12216
Net Cashflow-2964-8638259

What does the Key Ratio analysis of QUICK HEAL TECHNOLOGIES reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of QUICK HEAL TECHNOLOGIES reveals:

  • Operating profit margins witnessed a fall and down at 6.0% in FY24 as against 0.7% in FY23.
  • Net profit margins grew from 2.3% in FY23 to 8.3% in FY24.
  • Debt to Equity ratio for FY24 stood at 0.0 as compared to 0.0 in FY23.

Here's the ratio/financial analysis of QUICK HEAL TECHNOLOGIES for the past 5 years.

 FY20FY21FY22FY23FY24
Operating Profit Margin (%)31.941.331.30.76.0
Net Profit Margin (%)26.032.124.32.38.3
Debt to Equity Ratio (x)0.00.00.00.00.0

 

Equitymaster requests your view! Post a comment on "QUICK HEAL TECHNOLOGIES 2023-24 Annual Report Analysis". Click here!